QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 PHASE 3 STUDY OF FRONTLINE RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE PLUS VINCRISTINE (R-CHOP) OR BORTEZOMIB (VR-CAP) IN TRANSPLANTATION-UNSUITABLE MANTLE CELL LYMPHOMA (MCL) PATIENTS 会议论文 作者:  Robak, T.;  Huang, H.;  Jin, J.;  Zhu, J.;  Liu, T. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab 期刊论文 CLINICAL CANCER RESEARCH, 2013, 卷号: 19, 期号: 9 作者:  Coiffier, Bertrand;  Li, Weimin;  Henitz, Erin D.;  Karkera, Jayaprakash D.;  Favis, Reyna 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 Bortezomib-rituximab results in improved PFS and response rates versus rituximab, and quality of response is associated with improved outcomes, in patients with relapsed follicular lymphoma (FL) 期刊论文 Haematologica, 2011 作者:  Coiffier B., Osmanov E., Hong X., Scheliga A., Mayer J., Offner F., Rule S., Teixeira A., Walewski J., Crump M., Shpilberg O., Hermann R., Esseltine D.L., Zhu E., Enny C., Theocharous P., Van De Velde 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 A phase 3 trial comparing bortezomib plus rituximab with rituximab alone in patients with relapsed, rituximab-naive or-Sensitive, follicular lymphoma 期刊论文 Blood, 2010, 卷号: 116 作者:  Coiffier B., Osmanov E., Hong X., Scheliga A., Mayer J., Offner F.C., Rule S.A., Teixeira A., Walewski J.A., Crump M., Shpilberg O., Hermann R., Parasuraman S., Zhu E., Enny C., Theocharous P., Van De 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19